Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)

NCT00330863 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT00330863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00330863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Lead sponsor
Northwell Health
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
January 31, 2011
Enrollment
357 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia